Darberel 40mcg Injection

Darberel 40mcg Injection contains Darbepoetin Alfa, a hematopoietic growth factor used to treat anemia (low red blood cell count) in patients with chronic kidney disease or anemia resulting from chemotherapy in certain cancers.

Benefits

This injection helps increase the body's red blood cell production, which improves oxygen delivery to tissues. It effectively reduces the fatigue and weakness associated with anemia and can lessen the need for blood transfusions.

Uses and Indications

• Treatment of anemia in adult and pediatric patients with chronic kidney disease (CKD), including those receiving dialysis and those not on dialysis.
• Management of anemia caused by chemotherapy in adult cancer patients with non-myeloid malignancies.

The Darberel 40mcg Injection contains:

• Darbepoetin Alfa 40mcg (active ingredient).
• Excipients: Sodium Chloride, Polysorbate 80.

Dosage and Administration

1. Darberel 40mcg Injection is administered either subcutaneously (under the skin) or intravenously (into a vein).
2. A doctor determines the precise dose and frequency based on the patient's medical condition and hemoglobin levels.
3. Healthcare professionals typically administer this medicine, but patients may be trained for self-administration at home after receiving proper guidance.
4. Do not shake the vial or syringe before use. If self-administering, rotate injection sites to prevent irritation.

Storage and Disposal

• Store Darberel 40mcg Injection in a refrigerator between 2°C and 8°C.
• Do not freeze the injection.
• Keep the injection in its original packaging to protect it from light.
• Keep out of the sight and reach of children and pets.
• This product is for single use only; safely discard any unused portion.

Precautions and Safety

• Use Darberel 40mcg Injection strictly under the supervision of a qualified healthcare professional.
• Inform your doctor about any history of high blood pressure (controlled or uncontrolled), heart disease, stroke, seizures, sickle cell anemia, liver disease, or a latex allergy before starting treatment.
• Regular monitoring of blood pressure is essential during treatment, as this medicine can cause an increase in blood pressure.
• Consult your doctor if you are pregnant, planning pregnancy, or breastfeeding, as the safety of this medicine in these situations is not fully established.
• This medicine may increase the risk of blood clots, heart problems, or stroke. In some cancer patients, it may also accelerate tumor growth or shorten survival. Your doctor will discuss these risks.
• Do not use this medicine if you have uncontrolled high blood pressure or a history of pure red cell aplasia (a severe stop in red blood cell production) caused by similar medicines.

Side Effects and Risks

• Common side effects may include swelling in the face, body, legs, feet, ankles, or hands; low blood pressure (especially during dialysis); abdominal pain; shortness of breath; cough; headache; and pain or redness at the injection site.
• Seek immediate medical attention if you experience signs of an allergic reaction (hives, wheezing, swelling of the face or throat), severe skin reactions (blistering, peeling skin, fever), chest pain, heart attack symptoms, stroke symptoms (sudden numbness or weakness, confusion, severe headache, slurred speech, problems with vision or balance), seizures, or signs of a blood clot (pain, swelling, warmth, cold feeling, or pale appearance of an arm or leg).

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.